0000899243-20-032261.txt : 20201127
0000899243-20-032261.hdr.sgml : 20201127
20201127160849
ACCESSION NUMBER: 0000899243-20-032261
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201124
FILED AS OF DATE: 20201127
DATE AS OF CHANGE: 20201127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hunt Hazel
CENTRAL INDEX KEY: 0001698307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 201355394
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-24
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001698307
Hunt Hazel
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
0
1
0
0
Chief Scientific Officer
Common Stock
2020-11-24
4
M
0
50000
3.96
A
50200
D
Common Stock
2020-11-24
4
F
0
31225
22.88
D
18975
D
Stock Option (Right to Buy)
3.96
2020-11-24
4
M
0
50000
0.00
D
2021-01-03
Common Stock
50000
0
D
The shares were withheld at the election of the Reporting Person as payment for the purchased shares and to satisfy tax withholding obligations in connection with the purchase of the shares.
Fully exercisable.
/s/ G. Charles Robb, Attorney-in-Fact for Hazel Hunt
2020-11-27